company background image
001367 logo

Zhejiang Haisen Pharmaceutical SZSE:001367 Stock Report

Last Price

CN¥22.79

Market Cap

CN¥2.3b

7D

1.8%

1Y

-27.8%

Updated

15 Jul, 2024

Data

Company Financials

Zhejiang Haisen Pharmaceutical Co., Ltd.

SZSE:001367 Stock Report

Market Cap: CN¥2.3b

001367 Stock Overview

Engages in the research and development, production, and sale of chemical active pharmaceutical ingredient and intermediates in China.

001367 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance4/6
Financial Health6/6
Dividends2/6

Zhejiang Haisen Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Zhejiang Haisen Pharmaceutical
Historical stock prices
Current Share PriceCN¥22.79
52 Week HighCN¥38.51
52 Week LowCN¥17.94
Beta0
11 Month Change-11.89%
3 Month Change14.92%
1 Year Change-27.82%
33 Year Changen/a
5 Year Changen/a
Change since IPO-54.96%

Recent News & Updates

Zhejiang Haisen Pharmaceutical's (SZSE:001367) Shareholders May Want To Dig Deeper Than Statutory Profit

May 01
Zhejiang Haisen Pharmaceutical's (SZSE:001367) Shareholders May Want To Dig Deeper Than Statutory Profit

Recent updates

Zhejiang Haisen Pharmaceutical's (SZSE:001367) Shareholders May Want To Dig Deeper Than Statutory Profit

May 01
Zhejiang Haisen Pharmaceutical's (SZSE:001367) Shareholders May Want To Dig Deeper Than Statutory Profit

Shareholder Returns

001367CN PharmaceuticalsCN Market
7D1.8%-0.6%1.2%
1Y-27.8%-15.3%-18.5%

Return vs Industry: 001367 underperformed the CN Pharmaceuticals industry which returned -15.3% over the past year.

Return vs Market: 001367 underperformed the CN Market which returned -18.5% over the past year.

Price Volatility

Is 001367's price volatile compared to industry and market?
001367 volatility
001367 Average Weekly Movement6.2%
Pharmaceuticals Industry Average Movement5.8%
Market Average Movement6.7%
10% most volatile stocks in CN Market10.0%
10% least volatile stocks in CN Market4.3%

Stable Share Price: 001367 has not had significant price volatility in the past 3 months.

Volatility Over Time: 001367's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1998636Lin Aiwww.haisenpharma.com

Zhejiang Haisen Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical active pharmaceutical ingredient and intermediates in China. The company offers APIs for anti-gastric ulcer, antilipemic agent, antipyretic analgesics, antidepressant, analgesic, antibacterial agent, antipyretic analgesics, histamines drug, and anticonvulsant. It also provides chemical product for intermediates and food additives.

Zhejiang Haisen Pharmaceutical Co., Ltd. Fundamentals Summary

How do Zhejiang Haisen Pharmaceutical's earnings and revenue compare to its market cap?
001367 fundamental statistics
Market capCN¥2.29b
Earnings (TTM)CN¥113.05m
Revenue (TTM)CN¥406.30m

20.3x

P/E Ratio

5.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
001367 income statement (TTM)
RevenueCN¥406.30m
Cost of RevenueCN¥240.54m
Gross ProfitCN¥165.76m
Other ExpensesCN¥52.71m
EarningsCN¥113.05m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.12
Gross Margin40.80%
Net Profit Margin27.83%
Debt/Equity Ratio0%

How did 001367 perform over the long term?

See historical performance and comparison

Dividends

1.5%

Current Dividend Yield

29%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.